Jupiter Endovascular
CA - Menlo ParkBiotechnology
Focus: Jupiter Endovascular is a device-stage biotech company focused on endovascular solutions for pulmonary embolism, a high-acuity cardiovascular-respiratory indication. The company is pre-commercial with a single clinical program.
Profile data last refreshed 17h ago · AI intelligence enriched 2w ago
Open Jobs
2-3 this month
Stable — net -3 jobs in 30d
2 added, 5 removed. Backfill posture.
Should You Work at Jupiter Endovascular?
AI assessmentBest suited for early-stage device specialists willing to accept pre-revenue risk in exchange for potential equity upside and hands-on product development role.
Why Work Here
- Ground-floor opportunity at an early-stage device company with focus on high-acuity PE indication
- Hiring across manufacturing and R&D suggests active development phase and product maturation
Data completeness
2/9 — Limited
Company HealthSolid
Pipeline
Early-stage
1 total
LOE Risk
Protected
No near-term cliffs
Hiring
Stable
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Pipeline & Clinical Trials
Vertex Pulmonary Embolectomy System
Pulmonary EmbolismClinical Trials (1)
NCT06576427Selective Pulmonary-artery Intervention to Reduce Acute Right-heart tEnsion-II
N/AHelp build intelligence for Jupiter Endovascular
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.